Loading organizations...
§ Private Profile · Plymouth, MN, USA
Medical device company developing minimally invasive balloon dilation technologies for ENT physicians treating chronic rhinosinusitis.
Based in Plymouth, Minnesota, Entellus Medical develops minimally invasive balloon dilation technologies and medical devices for treating chronic rhinosinusitis and other ear, nose, and throat conditions. The company provides specialized products such as the XprESS Multi-Sinus Dilation System and the LATERA Absorbable Nasal Implant, which enable physicians to perform targeted procedures in an outpatient office setting as a less invasive alternative to traditional surgery. Prior to its public offering, the enterprise secured at least $92 million in venture capital funding from backers including Covidien Ventures, Split Rock Partners, and SV Life Sciences. In a strategic move to expand its commercial product portfolio, the firm acquired Spirox for $81 million before ultimately agreeing to be acquired by Stryker for $662 million in late 2017. Entellus Medical was founded in 2006 by Peter Keith.
Entellus Medical has raised $65.0M across 2 funding rounds.
Entellus Medical has raised $65.0M in total across 2 funding rounds.
Entellus Medical has raised $65.0M across 2 funding rounds. Most recently, it raised $35.0M Other Equity in August 2011.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 17, 2011 | $35M Venture Round | Covidien Ventures | Greenspring Associates, Split Rock Partners, SV Health Investors | Announced |
| Nov 17, 2009 | $30M Series D | — | Split Rock Partners, SV Health Investors | Announced |
Entellus Medical has raised $65.0M in total across 2 funding rounds.
Entellus Medical's investors include Covidien Ventures, Greenspring Associates, Split Rock Partners, SV Health Investors.